Compare STTK & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | MCFT |
|---|---|---|
| Founded | 2016 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 604.0M |
| IPO Year | 2020 | 2015 |
| Metric | STTK | MCFT |
|---|---|---|
| Price | $7.36 | $24.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $10.00 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 1.9M | 140.4K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | $1,000,000.00 | ★ $284,203,000.00 |
| Revenue This Year | N/A | $9.18 |
| Revenue Next Year | N/A | $8.23 |
| P/E Ratio | ★ N/A | $72.12 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $17.19 |
| 52 Week High | $8.33 | $28.44 |
| Indicator | STTK | MCFT |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 49.99 |
| Support Level | $5.87 | $21.90 |
| Resistance Level | $7.64 | $25.91 |
| Average True Range (ATR) | 0.62 | 0.88 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 71.63 | 44.00 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.